These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14498052)

  • 21. [Experiences with endoxan in the treatment of maligant tumors].
    KIRSCHKE W
    Chirurg; 1961 Aug; 32():372-5. PubMed ID: 13756301
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy of malignant disease.
    DAWSON WB
    Nurs Times; 1961 Dec; 57():1563-5. PubMed ID: 13884051
    [No Abstract]   [Full Text] [Related]  

  • 23. [Endoxan treatment of malignant tumors in otorhinolarygology].
    LOZERON H; LERUDULIER JL
    Praxis; 1961 Mar; 50():220-3. PubMed ID: 13763902
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of malignant hemoblastoses and neoplasms with Endoxan].
    KUEHBOECK J; REIMER EE; STOIBER T
    Arzneimittelforschung; 1961 Mar; 11():196-9. PubMed ID: 13754857
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of treatment of malignant tumors with N-mustard gas-phosphamide ester (endoxan)].
    SCHWENKENBECHER W
    Ther Ggw; 1959 Jun; 98(6):285-7. PubMed ID: 13676100
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy of melanoma of the extremities by isolated perfusion.
    CREECH O; KREMENTZ ET; RYAN RF
    Cancer Chemother Rep; 1962 Feb; 16():579-81. PubMed ID: 13882088
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experiences with endoxan].
    ECKHARDT S; SELLEI C; HARTAI F
    Munch Med Wochenschr; 1959 Dec; 101():2273-5. PubMed ID: 13819226
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison between the hematological side effects of cyclophosphamide and nitrogen mustard.
    NISSEN-MEYER R; HOST H
    Cancer Chemother Rep; 1960 Nov; 9():51-5. PubMed ID: 13729268
    [No Abstract]   [Full Text] [Related]  

  • 29. [Our initial experience with endoxan (B 518) therapy].
    PRCIC M
    Med Arh; 1959; 13():127-41. PubMed ID: 14434709
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experiences with the cytostatic drug Endoxan].
    KOHOUT J
    Arzneimittelforschung; 1961 Mar; 11():218-20. PubMed ID: 13757614
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with the cytostatic drug Endoxan].
    SCHUELLER H
    Med Welt; 1962 Feb; 6():307-9. PubMed ID: 13909410
    [No Abstract]   [Full Text] [Related]  

  • 32. THE TREATMENT OF CANCER BY ISOLATION PERFUSION.
    DONALDSON SS; FLETCHER WS
    Am J Nurs; 1964 Aug; 64():81-4. PubMed ID: 14180364
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of malignant disease with an alkylating agent: review of 100 patients treated with "Endoxan".
    REEVE TS
    Med J Aust; 1961 May; 48(1)():686-9. PubMed ID: 13740326
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
    SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V
    Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research with endoxan therapy of tumors in children].
    KOETTGEN U; WOLF M
    Med Klin; 1961 Jan; 56():15-8. PubMed ID: 15445395
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of endoxan on oxidative processes in model systems in vitro.
    Mileva M; Traikov L; Deliyska B
    Med Pregl; 2007; 60 Suppl 2():121-3. PubMed ID: 18928176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy using cyclic phosphamide esters].
    Gerhartz H
    Med Monatsschr; 1973 Sep; 27(9):395-7. PubMed ID: 4588488
    [No Abstract]   [Full Text] [Related]  

  • 38. [The diphosphopyridine nucleotide blood level as a criterium for controlled dosage of cytostatics E 39 and endoxan in inoperable tumors].
    BOLT W; RITZL F; TOUSSAINT R; ZERLETT G
    Klin Wochenschr; 1960 Jan; 38():71-4. PubMed ID: 13802378
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bilateral neoplasms of the orbit with lymphatic type elements treated with antimitotic agents (Endoxan)].
    BERTONCINI G; PARDUCCI F
    Ann Ottalmol Clin Ocul; 1961 Dec; 87():763-74. PubMed ID: 13868478
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364.
    RUNDLES W; GRIZZLE J; BONO VH; JONSSON U; HUGULEY CM; CORLEY CC
    Cancer Chemother Rep; 1962 Feb; 16():223-30. PubMed ID: 14495284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.